Sarepta Therapeutics Aktie
17,48
EUR
+0,18
EUR
+1,04
%
19,90
USD
+0,13
USD
+0,63
%
Sarepta Therapeutics jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Sarepta Therapeutics Aktie Analyse
| 26.04.16 | Sarepta Therapeutics Sector Perform | RBC Capital Markets | |
| 22.04.16 | Sarepta Therapeutics Sector Perform | RBC Capital Markets | |
| 20.05.15 | Sarepta Therapeutics Sector Perform | RBC Capital Markets | |
| 23.01.15 | Sarepta Therapeutics Sector Perform | RBC Capital Markets | |
| 28.10.14 | Sarepta Therapeutics Neutral | Robert W. Baird & Co. Incorporated |
Werbung
Werbung